Cultured meat grown from animal cells without slaughter offers potential welfare benefits but raises questions about biopsy welfare, cell line ethics, and production scaling.
Cultured meat represents a potentially transformative welfare technology that could dramatically reduce the number of animals slaughtered for food. The welfare implications of biopsy collection are modest compared to the welfare costs of conventional animal farming. However, current dependence on fetal bovine serum collected from unborn calves is an ethical problem that undermines the welfare case and is actively being addressed. If serum-free production is achieved at scale, cultured meat could represent one of the most significant animal welfare innovations in history. The welfare community has generally been cautiously supportive while monitoring serum dependence and production scale welfare implications.